What is the Pharmaids Pharmaceuticals Ltd share price today?

The share price of BSE:PHARMAID-X on 01 Oct 2026 (as of 15:06:32 IST) is ₹30.17.

What is the BSE:PHARMAID-X 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the BSE:PHARMAID-X 52 week high low range shows a high of ₹60.79 and a low of ₹25.6.

What is the Pharmaids Pharmaceuticals Ltd market cap?

As on 01 Oct 2026, Pharmaids Pharmaceuticals Ltd market cap is ₹1036870000.

What is the shareholding pattern of Pharmaids Pharmaceuticals Ltd Stock?

The shareholding pattern of Pharmaids Pharmaceuticals Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 32.99% Foreign Institutional Investors (FII): 0% Domestic Institutional Investors (DII): 0% Mutual Funds: 0% Retail & Others: 67.01% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Pharmaids Pharmaceuticals Ltd?

The Price-to-Earnings (PE) ratio of Pharmaids Pharmaceuticals Ltd is 0, and the Price-to-Book (PB) ratio is 2.0478, as on 01 Oct 2026.

Pharmaids Pharmaceuticals Share Price

28.90+0.82 (+2.92%)

-41.99% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+2.92%

1 Week

+4.26%

1 Month

-4.15%

3 Month

-18.59%

6 Month

-8.25%

YTD

-39.36%

1 Year

-41.99%

5 Year

+74.62%

10 Year

Max

+478.00%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

27.52

27.00

25.60

High

28.90

29.49

32.50

36.80

41.90

53.90

About

Pharmaids Pharmaceuticals Ltd manufacture herbal cough syrups cold tablets pain reliever tablets active charcoal tablets joint pain ointments and much more. They are established in the year 1991 and are Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMA-ANSE

DIVISLAB-ANSE

TORNTPHARM-ANSE

LAURUSLABS-ANSE

ZYDUSLIFE-ANSE

DRREDDY-ANSE

CIPLA-ANSE

MANKIND-ANSE

AUROPHARMA-ANSE

LUPIN-ANSE

PHARMAID-XNSE

LTP

1W Low

1W High

Market cap (₹)

1783.65+5.4 (0.30%)

1720.80

1809.65

4,25,150Cr

10017.6+302.6 (3.11%)

9866.35

10080.20

2,66,265Cr

4686.9+51.75 (1.12%)

4555

4700.70

1,76,301Cr

2320.7-71.3 (-2.98%)

2252.50

2442

1,25,352Cr

1202.1-41.9 (-3.37%)

1182.05

1266.15

1,23,591Cr

1367.5+17.3 (1.28%)

1337.30

1390.70

1,14,351Cr

1396+16 (1.16%)

1364.75

1400.60

1,12,474Cr

2506.8+18.05 (0.73%)

2457.35

2523.70

1,02,315Cr

1709.3+31.5 (1.88%)

1656.90

1724.50

97,757Cr

2023.2+14.2 (0.71%)

1989.10

2061.55

92,007Cr

29.45+1.73 (6.24%)

27.31

29.80

99Cr

Pharmaids Pharmaceuticals Share Price

28.90+0.82 (+2.92%)

-41.99% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years-

3 years-

Last year43%

Compounded Profit Growth

10 years-

5 years-

3 years-

Last year14%

Stock Price CAGR

10 years-

5 years11%

3 years-15%

1 year-44%

Return on Equity

10 years-23%

5 years-23%

3 years-22%

Last year-22%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	-	-	43%
-	-	-	14%
-	11%	-15%	-44%
-23%	-23%	-22%	-22%

Peer Comparison

Symbol

SUNPHARMA-A

DIVISLAB-A

TORNTPHARM-A

LAURUSLABS-A

ZYDUSLIFE-A

DRREDDY-A

CIPLA-A

MANKIND-A

AUROPHARMA-A

LUPIN-A

PHARMAID-X

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,783.65	₹425150 Cr	38.77	8.29	58.23	₹11479 Cr
10,017.6	₹266265 Cr	91.03	34.04	128.41	₹2568 Cr
4,686.9	₹176301 Cr	83	14.04	106.21	₹2163 Cr
2,320.7	₹125352 Cr	93.56	8.17	33.94	₹889 Cr
1,202.1	₹123591 Cr	27.39	9.42	62.53	₹5040 Cr
1,367.5	₹114351 Cr	40.84	11.08	59.2	₹4196 Cr
1,396	₹112474 Cr	38.82	10.86	52.6	₹3879 Cr
2,506.8	₹102315 Cr	45.62	17.23	76.26	₹1913 Cr
1,709.3	₹97757 Cr	26.33	17.95	96.84	₹3505 Cr
2,023.2	₹92007 Cr	16.64	30.95	154.35	₹5333 Cr
29.45	₹99 Cr	—	0.63	-0.75	-₹12 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
₹4 Cr	₹7 Cr	₹5 Cr	₹9 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹2 L	₹0	₹0	₹0	₹0	₹0	₹0	₹30 L
₹5 L	₹10 L	₹8 L	₹22 L	₹4 L	₹7 L	₹70,000	₹1 L	₹90,000	₹12 L	-₹90 L	-₹26 L	₹37 L	₹0	₹0	₹0	₹0	₹2 L
₹4 Cr	₹7 Cr	₹6 Cr	₹9 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹5 Cr	₹6 Cr	-₹88 L	-₹26 L	₹37 L	₹0	₹0	₹0	₹0	₹32 L
₹5 Cr	₹8 Cr	₹8 Cr	₹14 Cr	₹13 Cr	₹9 Cr	₹8 Cr	₹8 Cr	₹9 Cr	₹11 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹9 Cr	₹70 L	₹54 L	₹6 L	₹31 L
-₹70 L	-₹24 L	-₹2 Cr	-₹5 Cr	-₹5 Cr	-₹4 Cr	-₹3 Cr	-₹2 Cr	-₹3 Cr	-₹5 Cr	-₹2 Cr	-₹1 Cr	-₹1 Cr	-₹9 Cr	-₹70 L	-₹54 L	-₹6 L	₹1 L
₹60 L	₹65 L	₹72 L	₹1 Cr	₹1 Cr	₹1 Cr	₹49 L	₹34 L	₹26 L	₹77 L	₹0	₹0	₹10,000	₹20,000	₹0	₹0	₹30,000	₹0
₹2 Cr	-₹1 Cr	-₹4 Cr	-₹4 Cr	-₹7 Cr	-₹5 Cr	-₹4 Cr	-₹3 Cr	-₹4 Cr	-₹7 Cr	-₹2 Cr	-₹1 Cr	-₹1 Cr	-₹9 Cr	-₹70 L	-₹54 L	-₹6 L	₹90,000
₹2 Cr	-₹1 Cr	-₹3 Cr	-₹3 Cr	-₹5 Cr	-₹5 Cr	-₹3 Cr	-₹2 Cr	-₹3 Cr	-₹6 Cr	-₹2 Cr	-₹51 L	-₹1 Cr	-₹6 Cr	-₹71 L	-₹55 L	-₹14 L	₹90,000

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
—	—	—	—	—
₹35 Cr	₹35 Cr	₹35 Cr	₹21 Cr	₹10 Cr
₹0	₹0	₹0	₹35 L	₹0
₹12 Cr	₹24 Cr	₹37 Cr	₹67 L	-₹2 Cr
₹12 Cr	₹24 Cr	₹37 Cr	₹67 L	-₹2 Cr
₹48 Cr	₹59 Cr	₹72 Cr	₹22 Cr	₹9 Cr
-₹5 L	-₹4 Cr	-₹2 Cr	₹0	₹0
₹3 Cr	₹2 Cr	₹4 Cr	₹0	₹0
₹8 Cr	₹28 Cr	₹0	₹0	₹0
-₹12 Cr	-₹11 Cr	-₹7 Cr	-₹3 Cr	-₹36 L
₹4 Cr	₹5 Cr	₹5 Cr	₹0	₹0
₹18 L	₹78 L	₹62 L	₹0	₹0
₹3 Cr	₹26 Cr	₹3 Cr	-₹3 Cr	-₹36 L
—	—	—	—	—
₹3 Cr	₹16 Cr	₹5 Cr	₹2 Cr	₹2 Cr
₹12 Cr	₹7 Cr	₹5 Cr	₹24 L	₹13 L
₹9 Cr	₹5 Cr	₹1 Cr	₹0	₹0
₹5 L	₹12 L	₹8 L	₹0	₹0
₹24 Cr	₹29 Cr	₹12 Cr	₹2 Cr	₹2 Cr
₹75 Cr	₹109 Cr	₹85 Cr	₹22 Cr	₹11 Cr
₹21 Cr	₹35 Cr	₹5 Cr	₹0	₹0
—	—	—	—	—
₹59 Cr	₹81 Cr	₹66 Cr	₹1 Cr	₹51 L
₹5 Cr	₹5 Cr	₹2 Cr	₹1 Cr	₹48 L
₹54 Cr	₹77 Cr	₹63 Cr	₹11 L	₹3 L
₹6 Cr	₹5 Cr	₹7 Cr	₹2 Cr	₹45 L
₹2 Cr	₹6 Cr	₹72 L	₹1 Cr	₹8 Cr
₹2 Cr	₹1 Cr	₹0	₹0	₹0
₹64 Cr	₹88 Cr	₹71 Cr	₹3 Cr	₹8 Cr
—	—	—	—	—
₹0	₹0	₹0	₹3 Cr	₹0
₹41 L	₹12 Cr	₹4 Cr	₹0	₹89 L
₹3 Cr	₹3 Cr	₹3 Cr	₹2 Cr	₹1 Cr
₹13 L	₹82 L	₹5 Cr	₹13 Cr	₹41 L
₹3 Cr	₹40 L	₹16 L	₹0	₹0
₹4 Cr	₹4 Cr	₹2 Cr	₹20 L	₹3 L
₹11 Cr	₹21 Cr	₹14 Cr	₹18 Cr	₹3 Cr
-₹13 Cr	-₹8 Cr	₹2 Cr	₹16 Cr	₹23 L
₹0	₹0	₹0	₹12 L	₹0
₹75 Cr	₹109 Cr	₹85 Cr	₹22 Cr	₹11 Cr
₹14	₹17	₹20	₹10	₹8
₹14	₹17	₹20	₹10	₹8

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
-₹16 Cr	-₹17 Cr	-₹16 Cr	-₹10 Cr	₹14 L
₹2 Cr	₹5 Cr	₹4 Cr	₹5 L	₹84,120
₹10 Cr	-₹3 Cr	₹1 Cr	₹6 Cr	-₹41 L
-₹4 Cr	-₹15 Cr	-₹11 Cr	-₹4 Cr	-₹26 L
-₹4 Cr	-₹15 Cr	-₹11 Cr	-₹4 Cr	-₹26 L
₹23 Cr	-₹12 Cr	-₹75 Cr	-₹5 Cr	₹47 L
-₹20 Cr	₹23 Cr	₹78 Cr	₹21 Cr	₹0
-₹69 L	-₹4 Cr	-₹8 Cr	₹12 Cr	₹21 L
₹82 L	₹5 Cr	₹13 Cr	₹41 L	₹20 L
₹13 L	₹82 L	₹5 Cr	₹13 Cr	₹41 L

Fundamental Ratios

Consolidated

Standalone

No results found

Pharmaids Pharmaceuticals Share Price

28.90+0.82 (+2.92%)

-41.99% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Open a free Demat account in minutes to start investing and screening .

Pharmaids Pharmaceuticals Share Price

28.90+0.82 (+2.92%)

-41.99% past 1 Year

Shareholding summary

Promoters

32.99%

FII

DII

Others

67.01%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
32.99%	32.99%	32.99%	32.99%	32.99%	5.14%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
67.01%	67.01%	67.01%	67.01%	67.01%	94.86%

Bulk & block deals

Name

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange

Insider trading & SAST

Client name

Prasanna Subramanya Bhat

Pratima Subrahmanya Bhat

Shankarappa Nagaraja Vinaya Babu

Shreedhara Shetty

Shankarappa Nagaraja Vinaya Babu (Revised)

Maliemadom Ramaswamy Iyer Mahadevan

Shankarappa Nagaraja Vinaya Babu

Mini Manikantan

Maliemadom Ramaswamy Iyer Mahadevan

Shreedhara Shetty

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
08 Sep 2026	KMP	Acquisition	0.049028	0.06	0	—	17.29 K	03 Sep 2026	Gift	22,700	Insider Trading	—	Equity
08 Sep 2026	Immediate Relative	Disposal	0.049028	0	0	—	17.29 K	03 Sep 2026	Gift	963	Insider Trading	—	Equity
26 Sep 2025	Other	Acquisition	7.68	32.04	0	—	27.10 L	25 Aug 2025	Open Offer	1,12,99,064	SAST	29(2)	—
17 Sep 2025	Other	Disposal	2.51	14.53	0	—	8.85 L	18 Aug 2025	Open Offer	51,25,621	SAST	29(2)	—
15 Sep 2025	Director	Acquisition	0.283545	27.88	35 L	₹35	1 L	09 Sep 2025	Off Market	98,31,064	Insider Trading	—	Equity Shares
02 Sep 2025	Designated Person	Disposal	0.011342	0.35	2.46 L	₹61.50	4 K	29 Aug 2025	Market Sale	1,25,178	Insider Trading	—	Equity Shares
28 Aug 2025	Director	Acquisition	7.684659	27.59	16.84 Cr	₹62.15	27.10 L	25 Aug 2025	Others	97,31,064	Insider Trading	—	Equity Shares
20 Aug 2025	Director	Disposal	1.134179	0.28	2.49 Cr	₹62.15	4 L	14 Aug 2025	Others	1,00,000	Insider Trading	—	Equity Shares
20 Aug 2025	Designated Person	Disposal	0.425317	0.36	93.22 L	₹62.15	1.50 L	18 Aug 2025	Others	1,29,178	Insider Trading	—	Equity Shares
20 Aug 2025	Director	Disposal	2.509371	14.53	5.50 Cr	₹62.15	8.85 L	18 Aug 2025	Others	51,25,621	Insider Trading	—	Equity Shares

Pharmaids Pharmaceuticals Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Pharmaids Pharmaceuticals Share Price

Pharmaids Pharmaceuticals Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Pharmaids Pharmaceuticals Share Price

Pharmaids Pharmaceuticals Share Price

Oscillators

Moving averages

Pharmaids Pharmaceuticals Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Pharmaids Pharmaceuticals Share Price

Corporate Actions

Company details

Pharmaids Pharmaceuticals Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Pharmaids Pharmaceuticals Share Price

News

Pharmaids Pharma reports Profit after tax of Rs -1.31 Crores, in the March 2026 quarter

Pharmaids Pharmaceuticals informs about compliance report

Pharmaids Pharma reports Profit after tax of Rs -3.11 Crores, in the December 2025 quarter

Pharmaids Pharmaceuticals informs about voting results and scrutinizer report

Pharmaids Pharmaceuticals informs about appointment of independent director

Pharmaids Pharma reports Profit after tax of Rs -1.65 Crores, in the September 2025 quarter

Pharmaids Pharmaceuticals informs about open offer

Pharmaids Pharmaceuticals informs about proceedings of AGM

Pharmaids Pharma - Quaterly Results

Pharmaids Pharma reports Profit after tax of Rs -4.36 Crores, in the June 2025 quarter

Pharmaids Pharma - Quaterly Results

Pharmaids Pharma - Quaterly Results

Pharmaids Pharmaceuticals informs about letter of offer

Pharmaids Pharmaceuticals informs about certificate

Pharmaids Pharmaceuticals informs about trading window closure

Pharmaids Pharma - Quaterly Results

Pharmaids Pharma - Quaterly Results

Pharmaids Pharma reports Profit after tax of Rs -3.06 Crores, in the March 2025 quarter

Pharmaids Pharma - Quaterly Results

Pharmaids Pharmaceuticals informs about newspaper advertisement

Pharmaids Pharmaceuticals Ltd Share Price Today

Pharmaids Pharmaceuticals Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator